MedTrace Logo

Implementation of a Just-In-Time Adaptive Intervention for Adolescent Anxiety

NCT06946823 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-04-02

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate a smartphone based just-in-time adaptive intervention (JITAI) tool to deliver somatic behavioral recommendations for anxiety management among youth. The main questions it aims to answer are:

* Is the JITAI tool acceptable among the adolescent study population?
* Is the JITAI tool feasible to deliver to the adolescent study population?
* Does the study support preliminary efficacy of the JITAI tool among the adolescent study population?

The tool will be pilot-tested among a sample of 50 rural adolescents experiencing elevated anxiety levels who will be randomly assigned to the JITAI tool or a waitlist control, for a treatment period of 3 months.

Participants will be asked to:

* Use the smartphone based JITAI tool which will deliver somatic behavioral recommendations intended to manage anxiety levels for a treatment period of 3 months
* Respond to the tool's prompts on a daily basis and follow the delivered behavioral recommendations
* Complete anxiety and interoception assessments at study start, study end (3 months), and one-month follow-up
* Complete usability and user experience instruments at study end (3 months)

Conditions

  • Anxiety
  • Anxiety Disorders
  • Anxiety Disorder of Childhood

Interventions

DEVICE

Just-In-Time Adaptive Intervention for Adolescent Anxiety

A JITAI smartphone app to reduce anxiety levels among rural adolescents by delivering somatic-based activity recommendations

Sponsors & Collaborators

  • Trustees of Dartmouth College

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
13 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2027-01-31
Primary Completion
2027-05-31
Completion
2027-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06946823 on ClinicalTrials.gov